SOUTH SAN FRANCISCO, CA--(Marketwire - December 18, 2007) - Novacea, Inc. (NASDAQ: NOVC) today announced that Judith A. Hemberger, Ph.D., formerly co-founder, executive vice president and chief operating officer of Pharmion Corporation, has been elected to the Board of Directors. In addition, Mr. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals and a member of the Board of Directors since 2005, has been named the lead director.
